If you have celiac disease, eating foods that contain gluten can damage your villi, structures in the small intestine that ...

The only way to know if you have coeliac disease or gluten intolerance - While the two share many similar symptoms, only one ...

Before making changes to your diet, it’s a good idea to speak to your doctor or a qualified dietitian to make sure you don’t ...

“The FDA’s decision to grant Fast Track designation for TEV-53408, an investigational anti-IL-15 antibody therapy, reflects the promising nature of the treatment and the urgent unmet need of people ...

People with celiac disease can safely kiss their partners who have just ingested gluten, according to the results of a new study — though researchers recommend drinking some water first.

Since about 1 percent of the population has celiac disease and the symptoms can be dramatic, concern about inadvertent gluten transmission via kiss in not insignificant. Many partners of people with ...

People with celiac disease can kiss without fear, even if their partner has just eaten gluten, according to a new study. People with celiac disease have an immune response to gluten, a protein ...

Celiac disease is a serious autoimmune disorder that begins with something as small as a crumb of bread. Triggered by gluten—a protein found in wheat, barley, and rye—it causes the immune ...

Celiac disease prevalence is increasing, with higher incidence in women and children, often underdiagnosed due to nonclassical symptoms. Vitamin deficiencies in celiac disease, such as A ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Patients with celiac disease face an increased risk of developing any chronic liver disease. This risk increase can persist for at least 25 years after celiac diagnosis. The findings, published in ...

Topas Therapeutics has hailed a win for its immune-tolerance platform, reporting positive phase 2a data on its celiac disease candidate without sharing numbers to validate its upbeat outlook.